Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
Pricing research is often treated as a launch-stage exercise focused on testing a target price. But …
Read moreWhen the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) replaced VPAS in 2…
Read moreThe first EU Joint Clinical Assessments (JCAs) are now providing real-world evidence of how the new …
Read moreDifferent budget pressures create different payer pricing challenges Healthcare budget pressur…
Read moreThe publication of the first three EU Joint Clinical Assessments (JCAs) provides the first opportuni…
Read morePricing strategies rarely fail because of one decision. More often, price potential is gradually ero…
Read moreGermany’s SHI reform bill removes some of the most significant AMNOG restrictions introduced in 20…
Read moreIntroduction An EU-focused PICOS (population, intervention, comparator, outcomes or study-type) fram…
Read moreExecutive Summary Rare disease assessments rely on specialist clinical and patient expertise to inte…
Read more